108 related articles for article (PubMed ID: 11186365)
1. The DNA Rx. Advances in genetics give physicians ability to tailor drugs to patients' unique makeup.
Becker C
Mod Healthc; 2000 Aug; 30(36):24-8, 30, 33. PubMed ID: 11186365
[TBL] [Abstract][Full Text] [Related]
2. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
3. The coming pharmacogenomics revolution: tailoring drugs to fit patients' genetic profiles.
Noah L
Jurimetrics; 2002; 43(1):1-28. PubMed ID: 17333591
[TBL] [Abstract][Full Text] [Related]
4. Progress in pharmacogenomics and its promise for medicine.
Blake CA; Sobel BE
Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
[TBL] [Abstract][Full Text] [Related]
5. Measuring the value of pharmacogenomics.
Phillips KA; Van Bebber SL
Nat Rev Drug Discov; 2005 Jun; 4(6):500-9. PubMed ID: 15915153
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics and diagnostics.
Persidis A
Nat Biotechnol; 1998 Aug; 16(8):791-2. PubMed ID: 9702782
[No Abstract] [Full Text] [Related]
7. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
Mackler BF; Barach M
J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
[TBL] [Abstract][Full Text] [Related]
8. A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics.
Almarsdóttir AB; Björnsdóttir I; Traulsen JM
Health Policy; 2005 Feb; 71(2):233-41. PubMed ID: 15607385
[TBL] [Abstract][Full Text] [Related]
9. Translating pharmacogenomics: challenges on the road to the clinic.
Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
[TBL] [Abstract][Full Text] [Related]
10. Pushing drugs: genomics and genetics, the pharmaceutical industry, and the law of negligence.
Feldman HL
Washburn Law J; 2003; 42(3):575-99. PubMed ID: 15115000
[No Abstract] [Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. The challenges of delivering pharmacogenomics into clinical pediatrics.
Leeder JS; Kearns GL
Pharmacogenomics J; 2002; 2(3):141-3. PubMed ID: 12082583
[No Abstract] [Full Text] [Related]
13. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
14. How molecular medicine transforms policy (and everything else).
Kean MA; Batchelder KF
J Biolaw Bus; 2004; 7(3):16-9. PubMed ID: 15460603
[TBL] [Abstract][Full Text] [Related]
15. Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approach.
Mandry T
Food Drug Law J; 2004; 59(4):519-35. PubMed ID: 15875348
[TBL] [Abstract][Full Text] [Related]
16. The Human Genome Project: a public good.
Hudson K
Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
[No Abstract] [Full Text] [Related]
17. The future of highly personalized health care.
Robson B; Garnier J
Stud Health Technol Inform; 2002; 80():163-74. PubMed ID: 12026125
[TBL] [Abstract][Full Text] [Related]
18. Creating incentives for genomic research to improve targeting of therapies.
Evans BJ; Flockhart DA; Meslin EM
Nat Med; 2004 Dec; 10(12):1289-91. PubMed ID: 15580246
[No Abstract] [Full Text] [Related]
19. The life science revolution.
Enriquez J
Manag Care; 2002 Sep; 11(9 Suppl):15-8. PubMed ID: 12369338
[No Abstract] [Full Text] [Related]
20. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
